Applying human ADAR1p110 and ADAR1p150 for Site-Directed RNA editing—G/C substitution stabilizes guideRNAs against editing

Genes

Volumn 8, Issue 1, 2017, Pages

  Heep, Madeleine ^a   Mach, Pia ^a   Reautschnig, Philipp ^a   Wettengel, Jacqueline ^a   Stafforst, Thorsten ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

ADAR; Genetic disease; GuideRNA; RNA repair; Site directed RNA editing

Indexed keywords

ADENOSINE DEAMINASE; GUIDE RNA; PROTEIN ADAR1P110; PROTEIN ADAR1P150; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NUCLEIC ACID BASE SUBSTITUTION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA EDITING; RNA REPAIR; RNA SEQUENCE; RNA STABILITY; SITE DIRECTED RNA EDITING;

EID: 85009754998     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes8010034     Document Type: Article

References (28)

1. Vogel, P., Stafforst, T. Site-directed RNA editing with antagomir deaminases—A tool to study protein and RNA function. ChemMedChem 2014, 9, 2021-2025.
2. Nishikura, K. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 2010, 79, 321-349.
3. Stafforst, T., Schneider, M.F. An RNA-Deaminase conjugate selectively repairs point mutations. Angew. Chem. Int. Ed. 2012, 51, 11166-11169.
4. Montiel-Gonzalez, M.F., Guillermo, I., Yudowski, A., Rosenthal, J.J.C. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc. Natl. Acad. Sci. USA 2013, 110, 18285-18290.
5. Vogel, P., Schneider, M.F., Wettengel, J., Stafforst, T. Improving site-directed RNA editing in vitro and in cell culture by chemical modification of the guideRNA. Angew. Chem. Int. Ed. 2014, 53, 6267-6271.
6. Hanswillemenke, A., Kuzdere, T., Vogel, P., Jékely, G., Stafforst, T. Site-directed RNA editing in vivo can be triggered by the light-driven assembly of an artificial riboprotein. J. Am. Chem. Soc. 2015, 137, 15875-15881.
7. Wettengel, J., Reautschnig, J., Geisler, S., Kahle, P. J., Stafforst, T. Harnessing human ADAR2 for RNA repair—Recoding a PINK1 mutation rescues mitophagy. Nucl. Acids Res. 2016.
8. Bass, B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71, 817-846.
9. Schneider, M.F., Wettengel, J., Hoffmann, P.C., Stafforst, T. Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans. Nucl. Acids Res. 2004.
10. Picardi, E., Manzari, C., Mastropasqua, F., Aiello, I., D’Erchia, A.M., Pesole, G. Profiling RNA editing in human tissues: towards the inosinome Atlas. Sci. Rep. 2015.
11. Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 2016, 17, 83-96.
12. Barraud, P., Allain, F.H.-T. ADAR Proteins: Double-stranded RNA and Z-DNA binding domains. Curr. Topics Microbiol. Immun. 2012, 353, 35-60.
13. Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., Seeburg, P.H. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406, 78-81.
14. Hartner, J.C., Schmittwolf, C., Kispert, A., Müller, A.M., Higuchi, M., Seeburg, P.H. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 2004, 279, 4894-4902.
15. Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D.L., Weiss, M.J., Nishikura, K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 2004, 279, 4952-4961.
16. Morabito, M.V., Abbas, A.I., Hood, J.L., Kesterson, R.A., Jacobs, M.M., Kump, D.S., Hachey, D.L., Roth, B.L., Emeson, R.B. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol. Dis. 2010, 39, 169-180.
17. Maas, S., Kawahara, Y., Tamburro, K.M., Nishikura, K. A-to-I RNA editing and human disease. RNA Biol. 2006, 3, 1-9.
18. Slotkin, W., Nishikura, K. Adenosine-to-inosine RNA editing and human disease. Genome Med. 2013.
19. Silberberg, G., Lundin, D., Navon, R., Öhman, M. Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. Hum. Mol. Genet. 2012, 21, 311-321.
20. Rice, G.I., Kasher, P.R., Forte, G.M., Mannion, N.M., Greenwood, S.M., Szynkiewicz, M., Dickerson, J.E., Bhaskar, S.S., Zampini, M., Briggs, T.A., et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat. Genet. 2012, 44, 1243-1248.
21. Zhang, X.J., He, P.P., Li, M., He, C.D., Yan, K.L., Cui, Y., Yang, S., Zhang, K.Y., Gao, M., Chen, J.J., et al. Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH). Hum. Mutat. 2004, 23, 629-630.
22. Chen, L., Li, Y., Lin, C.H., Chan, T.H.M., Chow, R.K.K., Song, Y., Liu, M., Yuan, Y.F., Fu, L., Kong, K.L., et al. Recoding RNA editing of antizyme inhibitor 1 predisposes to hepatocellular carcinoma. Nat. Med. 2013, 19, 209-216.
23. Shimokawa, T., Rahman, M.F., Tostar, U., Sonkoly, E., Ståhle, M., Pivarcsi, A., Palaniswamy, R., Zaphiropoulos, P.G. RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biol. 2013, 10, 321-333.
24. Gallo, A. RNA editing enters the limelight in cancer. Nat. Med. 2013, 19, 130-131.
25. Paz-Yaacov, N., Bazak, L., Buchumenski, I., Porath, H.T., Danan-Gotthold, M., Knisbacher, B.A., Eisenberg, E., Levanon, E.Y. Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep. 2015, 13, 267-276.
26. Han, L., Diao, L., Yu, S., Xu, X., Li, J., Zhang, R., Yang, Y., Werner, H.M., Eterovic, A.K., Yuan, Y., et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 2015, 28, 515-528.
27. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucl. Acids Res. 2003, 31, 3406-3415.
28. Reautschnig, P., Vogel, P., Stafforst, T. The notorious RNA in the spotlight—Drug or target for the treatment of disease. RNA Biol. 2016.